Predicting utility of exercise tests based on history/holter in patients with premature ventricular contractions

Area of Science:

• Cardiology
• Electrophysiology
• Preventive Medicine

Background:

• Premature ventricular contractions (PVCs) are often benign in structurally normal hearts, especially when suppressed by exercise.
• Catecholaminergic polymorphic ventricular tachycardia (CPVT) presents a malignant phenotype that may be unmasked by exercise testing.
• Predicting the necessity of exercise testing for PVC patients is crucial for early diagnosis of conditions like CPVT.

Purpose of the Study:

• To identify risk factors and Holter monitor variables that predict the need for exercise testing in patients with PVCs.
• To differentiate between benign PVCs and potentially malignant arrhythmias like CPVT.

Main Methods:

• Retrospective review of 81 patients with PVCs that suppressed during exercise and 11 patients whose PVCs increased.
• Analysis of clinical risk factors (family history of arrhythmia/sudden unexpected death [SUD], syncope) and Holter parameters.
• Exercise testing was used to assess PVC suppression or augmentation.

Main Results:

• Family history of ventricular tachycardia (VT) or SUD and the presence of VT on Holter monitoring significantly predicted the failure of PVCs to suppress during exercise.
• Syncope was not a statistically significant predictor of PVC suppression, but four patients with syncope were diagnosed with CPVT.
• PVC quantity, Lown grade, couplets, monomorphism, and elimination at peak heart rate on Holter did not predict suppression.

Conclusions:

• Patients presenting with syncope during exercise, a family history of arrhythmia or SUD, or VT on Holter monitoring should undergo exercise testing.
• Exercise testing is essential for assessing the risk of CPVT in specific patient groups with PVCs.
• Identifying these risk factors aids in targeted diagnostic strategies for potentially life-threatening arrhythmias.